Bortezomib side effects

Bortezomib (Bortezomib) is an important anti-cancer drug, mainly used to treat malignant tumors such as multiple myeloma (Multiple Myeloma) and certain non-Hodgkin lymphoma (Non-Hodgkin Lymphoma). Although it has significant efficacy in treating cancer, it is also accompanied by some side effects, which may have varying degrees of impact on patients' quality of life. The following are common and serious side effects associated with bortezomib treatment:

1.Nausea and Vomiting: Nausea and vomiting are common side effects of bortezomib treatment. These symptoms may appear within a few hours of treatment but are usually relieved by the use of anti-nausea medications.

2.Diarrhea: Patients may experience diarrhea, possibly due to the irritating effects of bortezomib on the gastrointestinal tract.

3.Fatigue: Fatigue is one of the common adverse reactions, and patients may feel extremely tired and weak.

4.Peripheral neuropathy: Some patients may develop peripheral neuropathy, which may manifest as paresthesia, tingling, numbness, or tingling. This is called Bortezomib-Induced Peripheral Neuropathy, and it is a relatively common but important adverse reaction. It can affect a patient's quality of life and requires close monitoring during treatment.

5.Thrombocytopenia: Bortezomib may cause a decrease in the number of platelets, increasing the risk of bleeding and bruising. Patients may experience symptoms such as easy congestion, epistaxis, and bleeding gums.

6.Leukopenia: Leukopenia (a decrease in white blood cell count) is another potential adverse effect that may lead to decreased immune system function and increase the risk of infection.

7.Anemia: Bortezomib may cause anemia, a decrease in the number of red blood cells or hemoglobin levels. This can lead to fatigue and weakness.

8.Fever: Some patients may experience fever, which may be due to an inflammatory reaction caused by the drug.

9.Kidney impairment: Bortezomib can sometimes have adverse effects on the kidneys, leading to decreased kidney function. Renal function needs to be monitored closely during treatment.

10.Cardiovascular problems: Although relatively rare, bortezomib can also cause cardiovascular problems, such as high blood pressure and heart problems.

11.Liver Impairment: Some patients may develop liver function abnormalities, including elevated liver enzyme levels.

12.Pulmonary toxicity: Although less common, bortezomib has also been associated with pulmonary toxicity, which may cause symptoms such as coughing and dyspnea.

13.Elevated blood glucose: Some patients may experience an increase in blood glucose while taking bortezomib, which may require diabetes management.

It needs to be emphasized that the degree of side effects of bortezomib varies among individual patients, and during treatment, doctors will actively monitor and manage these side effects to minimize discomfort and ensure patient effectiveness.

Patients and doctors need to work closely together to regularly evaluate the effects and adverse reactions of treatment so that treatment plans can be adjusted in a timely manner. In addition, patients should participate in treatment as recommended by their doctor and follow recommended lifestyle and dietary changes to mitigate the risk of adverse effects and increase the success of treatment.

Bortezomib is already on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of around 3,000 to 4,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement policies. The cheaper ones abroad are mainly Indian generic drugs, which cost around 1,000 yuan and have basically the same ingredients as the domestic bortezomib drug.